日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer

染色质可及性和先锋因子FOXA1限制前列腺癌中糖皮质激素受体的活性

Laura Helminen ,Jasmin Huttunen ,Melina Tulonen ,Niina Aaltonen ,Einari A Niskanen ,Jorma J Palvimo ,Ville Paakinaho

Structural insights into the cooperative nucleosome recognition and chromatin opening by FOXA1 and GATA4

FOXA1和GATA4协同识别核小体和开放染色质的结构解析

Bing-Rui Zhou ,Hanqiao Feng ,Furong Huang ,Iris Zhu ,Stephanie Portillo-Ledesma ,Dan Shi ,Kenneth S Zaret ,Tamar Schlick ,David Landsman ,Qianben Wang ,Yawen Bai

Systematic dissection of sequence features affecting binding specificity of a pioneer factor reveals binding synergy between FOXA1 and AP-1

对影响先导因子结合特异性的序列特征进行系统性分析,揭示了FOXA1和AP-1之间的结合协同作用。

Cheng Xu ,Holly Kleinschmidt ,Jianyu Yang ,Erik M Leith ,Jenna Johnson ,Song Tan ,Shaun Mahony ,Lu Bai

Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis

非典型炎症激酶IKBKE磷酸化并灭活FoxA1,从而促进肝脏肿瘤发生

Bing Gao ,Xueji Wu ,Lang Bu ,Qiwei Jiang ,Lei Wang ,Haining Liu ,Xiaomei Zhang ,Yuanzhong Wu ,Xiaoxing Li ,Jingting Li ,Ying Liang ,Lixia Xu ,Wei Xie ,Jianping Guo

EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells

EP300/CREBBP乙酰转移酶抑制可限制前列腺癌细胞中的类固醇受体和FOXA1信号传导。

Jasmin Huttunen ,Niina Aaltonen ,Laura Helminen ,Kirsi Rilla ,Ville Paakinaho

PRKAG2.2 is essential for FoxA1+ regulatory T cell differentiation and metabolic rewiring distinct from FoxP3+ regulatory T cells

PRKAG2.2对于FoxA1+调节性T细胞的分化和代谢重编程至关重要,这与FoxP3+调节性T细胞不同。

Sara Mandatori ,Yawei Liu ,Joana Marturia-Navarro ,Mahdieh Hadi ,Kristine Henriksen ,Jin Zheng ,Louise Munk Rasmussen ,Salvatore Rizza ,Klaus H Kaestner ,Shohreh Issazadeh-Navikas

FOXA1 regulates alternative splicing in prostate cancer

FOXA1调控前列腺癌中的选择性剪接

Marco Del Giudice ,John G Foster ,Serena Peirone ,Alberto Rissone ,Livia Caizzi ,Federica Gaudino ,Caterina Parlato ,Francesca Anselmi ,Rebecca Arkell ,Simonetta Guarrera ,Salvatore Oliviero ,Giuseppe Basso ,Prabhakar Rajan ,Matteo Cereda

FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A

FOXA1通过转录抑制HIF1A来抑制缺氧程序

Xiaohai Wang # ,Lourdes Brea # ,Xiaodong Lu ,Galina Gritsina ,Su H Park ,Wanqing Xie ,Jonathan C Zhao ,Jindan Yu

High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer

FOXA1 免疫组织化学表达水平高与上皮性卵巢癌的粘液组织学、良好的临床病理预后参数和生存优势相关

Heba Sheta, Amal Abd El Hafez, Maha Saif, Alyaa R Elsergany, Doaa Al Emam, Mahmoud Mohamed Abdelrazik

FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

FOXA1突变会改变先锋活性、分化和前列腺癌表型

Elizabeth J Adams ,Wouter R Karthaus ,Elizabeth Hoover ,Deli Liu ,Antoine Gruet ,Zeda Zhang ,Hyunwoo Cho ,Rose DiLoreto ,Sagar Chhangawala ,Yang Liu ,Philip A Watson ,Elai Davicioni ,Andrea Sboner ,Christopher E Barbieri ,Rohit Bose ,Christina S Leslie ,Charles L Sawyers